Press-release for stocks related to biotechnology for snynf

tags : Biotechnology symbols : Snynf

save search

AbbVie Tops Doctor Ranking of Immunology Companies, Handily Beating Pfizer and J&J
Published: 2024-04-22 (Crawled : 13:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| 1.18% | O: 0.29% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| 2.56% | O: 0.85% H: 0.0% C: 0.0%
abbvie immunology

23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer
Published: 2024-04-22 (Crawled : 05:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| 2.56% | O: 0.85% H: 0.0% C: 0.0%
pharma cancer for

J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations?
Published: 2024-04-19 (Crawled : 13:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| 3.25% | O: 0.83% H: 1.35% C: 1.2%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| 3.41% | O: 0.82% H: 0.0% C: 0.0%
miss

Listen Up: Emerging Vocal Biomarker Could Aid ALS Drug Development
Published: 2024-04-15 (Crawled : 05:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| 1.45% | O: -0.53% H: 0.61% C: 0.61%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| 2.36% | O: 1.95% H: 0.0% C: 0.0%
drug als biomarker

AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -0.73% | O: -3.02% H: 0.0% C: 0.0%
label children astrazeneca

Sanders Blasts Novo Nordisk for ‘Outrageous’ Price of Ozempic, Wegovy
Published: 2024-03-28 (Crawled : 12:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -5.47% | O: -1.17% H: 0.0% C: -0.89%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -4.13% | O: 1.32% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -5.35% | O: -0.96% H: 0.0% C: 0.0%
wegovy

COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024: GlobalData
Published: 2024-03-27 (Crawled : 12:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -5.71% | O: -0.26% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -4.35% | O: 1.06% H: 0.0% C: 0.0%
copd potential market

FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug Rejected
Published: 2024-03-11 (Crawled : 14:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| 0.79% | O: 0.0% H: 2.38% C: 1.12%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -5.84% | O: 0.43% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| -10.93% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -2.08% | O: 0.57% H: 0.0% C: 0.0%
fda drug wegovy approved

AstraZeneca, Sanofi’s Beyfortus 90% Effective at Preventing RSV Hospitalizations: CDC
Published: 2024-03-08 (Crawled : 15:30) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -2.16% | O: -0.08% H: 0.0% C: 0.0%
beyfortus rsv

ALS Treatment Landscape ‘Primed’ with Over 100 Candidates: GlobalData
Published: 2024-03-04 (Crawled : 13:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -0.26% | O: -0.9% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -0.68% | O: -0.8% H: 0.0% C: 0.0%
als treatment 100

Rare Disease Drug Development Urgently Needs More Funding, Experts Say
Published: 2024-02-29 (Crawled : 06:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -2.28% | O: -1.6% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -2.05% | O: -0.11% H: 0.0% C: 0.0%
rare drug disease

FDA Decisions: CMC Issues Thwart Venatorx and Melinta’s Urinary Tract Infection Antibiotic
Published: 2024-02-23 (Crawled : 19:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| -4.15% | O: 0.22% H: 0.85% C: 0.85%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -6.72% | O: 0.28% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| -9.6% | O: 0.28% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -1.78% | O: 0.97% H: 0.0% C: 0.0%
fda infection

Sanofi, Regeneron Secure FDA Priority Review for Dupixent in COPD
Published: 2024-02-23 (Crawled : 15:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -1.78% | O: 0.97% H: 0.0% C: 0.0%
fda dupixent review copd

VC Firm’s New $260M Fund Taps AI to Identify Biotechs Poised for Success
Published: 2024-02-22 (Crawled : 17:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -1.52% | O: 0.26% H: 1.36% C: 1.36%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -0.15% | O: 1.67% H: 0.0% C: 0.0%
success

Ex-Google DeepMind and Owkin scientists team up to create Bioptimus to build the first universal AI foundation model for biology
Published: 2024-02-20 (Crawled : 10:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| 2.06% | O: 2.72% H: 0.0% C: -0.8%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| 1.8% | O: 2.53% H: 0.0% C: 0.0%
first universal

FDA Decisions: AstraZeneca, Iovance Win Approvals for NSCLC, Advanced Melanoma
Published: 2024-02-19 (Crawled : 15:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| Email alert Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| Email alert Add to watchlist
SNYNF | News | $94.25 -2.18% 480

Health Technology

| Email alert Add to watchlist
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| Email alert Add to watchlist
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| Email alert Add to watchlist
fda melanoma advanced

Smart Immune appoints key new members to its Board of Directors
Published: 2024-02-16 (Crawled : 09:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology